CSIMarket
 


Human Genome Sciences Inc  (HGSI)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

HGSI's Income from Cont. Operations Growth by Quarter and Year

Human Genome Sciences Inc's Income from Cont. Operations results by quarter and year




HGSI Income from Cont. Operations (in millions $) FY 2012 FY 2011 FY 2010 FY 2009
IV Quarter December - 0.00 0.00 0.00
III Quarter September - 0.00 0.00 0.00
II Quarter June -92.80 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -92.80 0.00 0.00 0.00



HGSI Income from Cont. Operations second quarter 2012 Y/Y Growth Comment
Human Genome Sciences Inc in the second quarter 2012 recorded loss from continued operations of $ -92.80 millions.

According to the results reported in the second quarter 2012, Human Genome Sciences Inc achieved the best Income from Cont. Operations growth in Medical Laboratories industry. While Human Genome Sciences Inc' s Income from Cont. Operations no change of % ranks overall at the positon no. in the second quarter 2012.




HGSI Income from Cont. Operations ( Y/Y Growth %) 2012
2011 2010 2009
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Human Genome Sciences Inc's second quarter 2012 Income from Cont. Operations $ -92.80 millions HGSI's Income Statement
Human Genome Sciences Inc's second quarter 2011 Income from Cont. Operations $ 0.00 millions Quarterly HGSI's Income Statement
New: More HGSI's historic Income from Cont. Operations Growth >>


HGSI Income from Cont. Operations (Quarter on Quarter Growth %)

2012
2011 2010 2009
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations second quarter 2012 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations second quarter 2012 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2009, 2010, 2011, 2012

Human Genome Sciences Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HGSI's II. Quarter Q/Q Income from Cont. Operations Comment


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HGSI's II. Quarter Q/Q Income from Cont. Operations Comment


Human Genome Sciences Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2012)
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Income from Cont. Operations 12 Months Ending $ -92.80 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Human Genome Sciences Inc' has realized cumulative trailing twelve months loss from continued operations of $ -93 millions in the Jun 30 2012 period.
The business is detiriorating as the cumulative loss from continued operations is becoming larger from $ 0 millions in TTM ending quarter and $ millions for the twelve months ending in the quarter a year ago.

Human Genome Sciences Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Human Genome Sciences Inc' has realized cumulative trailing twelve months loss from continued operations of $ -93 millions in the Jun 30 2012 period.
The results are worsening as the cumulative loss from continued operations is becoming larger from $ 0 millions in TTM ending quarter and $ millions for the twelve months ending in the quarter .

Human Genome Sciences Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Medical Laboratories Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
HGSI's Income from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for HGSI's Competitors
Income from Cont. Operations Growth for Human Genome Sciences Inc's Suppliers
Income from Cont. Operations Growth for HGSI's Customers

You may also want to know
HGSI's Annual Growth Rates HGSI's Profitability Ratios HGSI's Asset Turnover Ratio HGSI's Dividend Growth
HGSI's Roe HGSI's Valuation Ratios HGSI's Financial Strength Ratios HGSI's Dividend Payout Ratio
HGSI's Roa HGSI's Inventory Turnover Ratio HGSI's Growth Rates HGSI's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Jun 30 2012 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jun 30 2012
Waters Corp-2.35%$ -2.349 millions
Davita Inc -4.68%$ -4.677 millions
Gilead Sciences Inc -4.90%$ -4.901 millions
Mylan N v -5.39%$ -5.392 millions
Becton Dickinson And Company-7.85%$ -7.846 millions
Abbvie inc -11.23%$ -11.230 millions
Abbott Laboratories-11.23%$ -11.230 millions
Merck and Co Inc -11.39%$ -11.392 millions
Eli Lilly And Company-22.86%$ -22.860 millions
Bristol myers Squibb Company-28.49%$ -28.492 millions
Johnson and Johnson-49.28%$ -49.280 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com